Qpex Biopharma Secures $33 Million Series A
October 25, 2018
12:23 pm
Qpex Biopharma closed a $33 million Series A financing round and launched its infectious disease company. New Enterprise Associates led the financing syndicate featuring Adams Street Partners, LYZZ Capital, Hatteras Venture Partners, and Stanford University Draper Fund. Additional funding is being provided through an agreement
